Skip to content

Clinical trials

Terminated Phase 2 Recurrence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2 Status: Terminated Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20058
20067
20079
20087
20097
201012
20113
201212
20133
20145
20153
20164
20175
20186
20197
20205
20212
20225
20234
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated124

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lee Moffitt Cancer Center and Research Institute4
M.D. Anderson Cancer Center4
Memorial Sloan Kettering Cancer Center3
Weill Medical College of Cornell University3
Burzynski Research Institute2
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
Dana-Farber Cancer Institute2
Lymphoma Study Association2
NYU Langone Health2
National Cancer Institute (NCI)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence124
Multiple Myeloma20
Neoplasm Metastasis15
Neoplasms14
Leukemia, Myeloid, Acute13
Lymphoma12
Lymphoma, Large B-Cell, Diffuse12
Leukemia, Lymphocytic, Chronic, B-Cell11
Hodgkin Disease10
Lymphoma, Mantle-Cell10

Trials

Showing 1 to 25 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.